Skip to content
Disclosery

EXANE DERIVATIVES: LOGI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on LOGI, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 7,175 LOGI shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 7,175 shares
    Change vs previous 13F -650 shares

    0.21% of the 13F portfolio, value $373,365.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 7,825 shares
    Change vs previous 13F -1,073 shares

    0.16% of the 13F portfolio, value $581,463.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 8,898 shares
    Change vs previous 13F -27,187 shares

    0.18% of the 13F portfolio, value $750,062.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 36,085 shares
    Change vs previous 13F +34,713 shares

    0.8% of the 13F portfolio, value $3,212,597.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,372 shares
    Change vs previous 13F -53 shares

    0.04% of the 13F portfolio, value $167,367.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,425 shares
    Change vs previous 13F -98 shares

    0.05% of the 13F portfolio, value $149,658.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,523 shares
    Change vs previous 13F -68,714 shares

    0.05% of the 13F portfolio, value $148,679.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 70,237 shares
    Change vs previous 13F not available

    1.78% of the 13F portfolio, value $5,456,642.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).